Merck announced a price increase on a number of vaccines on Nov. 14, including GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant), M-M-R®II (Measles, Mumps, and Rubella Virus Vaccine Live), PNEUMOVAX®23 (Pneumococcal Vaccine Polyvalent), VAQTA® (Hepatitis A Vaccine, Inactivated) (50U/1 mL), and VARIVAX® (Varicella Virus Vaccine Live). However, APCI's contract with Merck provides for a 14-day price increase protection, meaning that APCI members have a brief window to purchase the vaccines at the pre-increase price.

This is a great opportunity for APCI members to buy-in Pneumovax (GREAT COMBO WITH FLU VACCINATIONS)

Order now through Nov. 27 to get the old pricing which is a 6 percent savings on Pneumovax.

Click on the image below to view a larger image with pricing details (image opens in a new window).

You may also click here to view a PDF of APCI's contract terms and conditions, including updated pricing as of Nov. 15 (PDF opens in a new window)

For questions please contact the Merck Vaccine Customer Center at 1-877-VAX-MERCK (1-877-829-6372), the Merck Order Management Center 1-800-MERCK-RX (1-800-637-2579), or your Merck Vaccine Account Executive.